Tower Research Capital LLC (TRC) - CONTEXT THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CONTEXT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,534
+42.5%
8,963
+51.0%
0.00%
Q2 2023$9,499
+189880.0%
5,937
-32.9%
0.00%
Q1 2023$5
-16.7%
8,843
-0.2%
0.00%
Q4 2022$6
-99.9%
8,857
+21.3%
0.00%
Q3 2022$8,000
+33.3%
7,299
+145.9%
0.00%
Q2 2022$6,0002,968
+8893.9%
0.00%
Q1 2022$0
-100.0%
33
-98.4%
0.00%
Q4 2021$6,0002,0540.00%
Other shareholders
CONTEXT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,165,100$2,528,0000.38%
Worth Venture Partners, LLC 317,729$689,0000.32%
Affinity Asset Advisors, LLC 777,610$1,687,0000.27%
Knoll Capital Management, LLC 139,520$303,0000.19%
swisspartners Ltd. 42,235$92,0000.07%
Veritable, L.P. 110,249$239,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 49,912$108,0000.00%
MORGAN STANLEY 10,000$22,0000.00%
BlackRock Inc. 16,961$37,0000.00%
Citadel Advisors 18,516$40,0000.00%
View complete list of CONTEXT THERAPEUTICS INC shareholders